Interacting Drugs |
Lidocaine and hydrocortisone vs CYP1A2 Substrates |
Security Level |
 |
Mechanism |
CYP1A2 Substrates: CYP1A2 Inhibitors (Strong) may decrease the metabolism of CYP1A2 Substrates. |
Management |
Consider therapy modification |
Lidocaine and hydrocortisone vs CYP1A2 Substrates
Post Review about Lidocaine and hydrocortisone vs CYP1A2 Substrates Click here to cancel reply.
Other Interactions of Lidocaine and hydrocortisone
Other Interactions of CYP1A2 Substrates
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.